Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec;39(12):1730-41.
doi: 10.1097/PAS.0000000000000533.

A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas

Olca Basturk  1 , Seung-Mo Hong, Laura D Wood, N Volkan Adsay, Jorge Albores-Saavedra, Andrew V Biankin, Lodewijk A A Brosens, Noriyoshi Fukushima, Michael Goggins, Ralph H Hruban, Yo Kato, David S Klimstra, Günter Klöppel, Alyssa Krasinskas, Daniel S Longnecker, Hanno Matthaei, G Johan A Offerhaus, Michio Shimizu, Kyoichi Takaori, Benoit Terris, Shinichi Yachida, Irene Esposito, Toru Furukawa; Baltimore Consensus Meeting
Affiliations

A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas

Olca Basturk et al. Am J Surg Pathol. 2015 Dec.

Abstract

International experts met to discuss recent advances and to revise the 2004 recommendations for assessing and reporting precursor lesions to invasive carcinomas of the pancreas, including pancreatic intraepithelial neoplasia (PanIN), intraductal papillary mucinous neoplasm (IPMN), mucinous cystic neoplasm, and other lesions. Consensus recommendations include the following: (1) To improve concordance and to align with practical consequences, a 2-tiered system (low vs. high grade) is proposed for all precursor lesions, with the provision that the current PanIN-2 and neoplasms with intermediate-grade dysplasia now be categorized as low grade. Thus, "high-grade dysplasia" is to be reserved for only the uppermost end of the spectrum ("carcinoma in situ"-type lesions). (2) Current data indicate that PanIN of any grade at a margin of a resected pancreas with invasive carcinoma does not have prognostic implications; the clinical significance of dysplasia at a margin in a resected pancreas with IPMN lacking invasive carcinoma remains to be determined. (3) Intraductal lesions 0.5 to 1 cm can be either large PanINs or small IPMNs. The term "incipient IPMN" should be reserved for lesions in this size with intestinal or oncocytic papillae or GNAS mutations. (4) Measurement of the distance between an IPMN and invasive carcinoma and sampling of intervening tissue are recommended to assess concomitant versus associated status. Conceptually, concomitant invasive carcinoma (in contrast with the "associated" group) ought to be genetically distinct from an IPMN elsewhere in the gland. (5) "Intraductal spread of invasive carcinoma" (aka, "colonization") is recommended to describe lesions of invasive carcinoma invading back into and extending along the ductal system, which may morphologically mimic high-grade PanIN or even IPMN. (6) "Simple mucinous cyst" is recommended to describe cysts >1 cm having gastric-type flat mucinous lining at most minimal atypia without ovarian-type stroma to distinguish them from IPMN. (7) Human lesions resembling the acinar to ductal metaplasia and atypical flat lesions of genetically engineered mouse models exist and may reflect an alternate pathway of carcinogenesis; however, their biological significance requires further study. These revised recommendations are expected to improve our management and understanding of precursor lesions in the pancreas.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Low-grade PanINs. A. Low-grade PanIN previously regarded as PanIN-1a in WHO 2010. B. Low-grade PanIN previously regarded as PanIN-1b in WHO 2010. C and D. Low-grade PanIN previously regarded as PanIN-2 in WHO 2010. All panels are hematoxylin and eosin staining. Original magnifications were A–C, 10×; D, 20×.
Figure 2
Figure 2
High-grade PanIN previously regarded as PanIN-3 in WHO 2010. This lesion may be termed as carcinoma in situ in some geographical regions. Hematoxylin and eosin staining. An original magnification was 20×.
Figure 3
Figure 3
IPMNs in various grades. A. IPMN, low-grade, previously regarded as IPMN with low-grade dysplasia in WHO 2010. B. IPMN, low-grade, previously regarded as IPMN with intermediate-grade dysplasia in WHO 2010. C and D. IPMN, high-grade, previously regarded as IPMN with high-grade dysplasia in WHO 2010. All panels are hematoxylin and eosin staining. Original magnifications were A, 4×; B–D, 20×.
Figure 4
Figure 4
Incipient IPMN lined with intestinal-type papillae.
Figure 5
Figure 5
Intraductal spread of invasive carcinoma. Highly atypical epithelia undistinguishable from invasive carcinoma line a duct. Front-formation between normal cuboidal epithelia and the atypical epithelia can be recognized. Hematoxylin and eosin staining. An original magnification was 10×.
Figure 6
Figure 6
Macroscopic cyst with flat mucinous lining. A cyst with predominantly flat mucinous lining with gastric phenotype is shown. Note no ovarian-like stroma. Hematoxylin and eosin staining. An original magnification was 20×.
Figure 7
Figure 7
Acinar-ductal metaplasia (ADM) and the atypical flat lesion (AFL) in the human pancreas. AC: ADM presents as an intralobular change characterized by progressive replacement of acini by ductular structures, which might display intracytoplasmic mucin, thereby resembling low-grade PanIN. Arrows indicate hybrid ductuli with co-expression of trypsin (B) and CK7 (C). Scale bars: 200μm. D–F: AFL are intralobular ductular proliferations with cytological atypia surrounded by a loose matrix with inflammatory infiltrates. AFL are located in ADM areas and may show focally retained tryspin expression (E), but mostly display a ductal phenotype with strong and diffuse CK7 staining (F). Scale bars: 200μm.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol. 2001;25:579–586. - PubMed
    1. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28:977–987. - PubMed
    1. Hruban RH, Pitman MB, Klimstra DS. Tumors of the pancreas. Washington, DC: American Registry of Pathology; 2007.
    1. Adsay NV, Fukushima N, Furukawa T, et al. Intraductal neoplasms of the pancreas. In: Bosman FT, Hruban RH, Carneiro F, et al., editors. WHO Classification of Tumours of the Digestive System. Lyon: IARC; 2010. pp. 304–313.
    1. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res. 2006;66:95–106. - PubMed

Publication types

MeSH terms